Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Cancer Research - United States
doi 10.1158/0008-5472.can-04-4212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction: Recognition of Lewis X by Anti-Lex Monoclonal Antibody 1G5F6

Journal of Immunology
AllergyImmunology
2020English

The Therapeutic Monoclonal Antibody Market

mAbs
AllergyImmunology
2015English

Long-Lasting Protective Antiviral Immunity Induced by Passive Immunotherapies Requires Both Neutralizing and Effector Functions of the Administered Monoclonal Antibody

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Production of a Monoclonal Antibody Specific for Pou5f1/Oct4

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2013English

A Monoclonal Antibody Specific for Mouse Dendritic Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Expression Vector-Derived Heterogeneity in a Therapeutic IgG4 Monoclonal Antibody

mAbs
AllergyImmunology
2018English

Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib

Clinical Cancer Research
Cancer ResearchOncology
2008English

Production of a Monoclonal Antibody Specific for Citrus Tristeza Virus

Food and Agricultural Immunology
ImmunologyAgronomyCrop ScienceFood Science
2003English

Characterization of a Monoclonal Antibody Specific for Human Active Renin

Hypertension
Internal Medicine
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy